Frequently Asked Questions – Secondary care services and the Falsified Medicines Directive (FMD) Version 2 (July 2018)

The MHRA produces a monthly newsletter about progress towards UK implementation of EU Falsified Medicines Directive. The newsletter is available by email request only to FMD.safetyfeatures@mhra.gov.uk.
The following Frequently Asked Questions have been produced to help raise awareness and understanding across secondary care. This update includes new questions raised to the above email address plus other forums including the Welsh pharmacy FMD working group.

Acute CareGuidance and GovernancePolicy, Commissioning and ManagerialQ&ASystem Safety

Attachments